Medicamen IPO

Medicamen Organics Ltd

₹1,28,000 /4000 sharesMinimum Investment

Medicamen IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹34.00₹137.85₹103.85 (305.44%)

Medicamen IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
21 Jun ‘24 - 25 Jun ‘24₹1,28,0004,000₹32 - ₹34
Issue SizeIPO Doc
10.54Cr
RHP PDF

About the company

Medicamen Organics Limited, incorporated in 1995 as Panchdeep Pharmaceuticals, is engaged in the manufacturing of pharmaceutical formulations and products, including tablets, capsules, oral liquids, and ointments. The company operates two WHO-GMP certified plants located in Haridwar. The product portfolio of Medicamen consists of 84 pharmaceutical products. These belong to the anti-bacterial, anti diarrheal, anti-fungal, anti-diabetic, proton pump inhibitor, multi-vitamin, multi-mineral and non-steroidal anti-inflammatory drug (NSAIDS) categories. The company has an in-house testing facility and sources its raw materials from FDA-approved sources. The company exports its products to countries on the African continent, CIS and SAARC countries. It is registered in 13 countries. The company’s products are marketed across India, Africa, Commonwealth of Independent States (CIS) and countries in south-east Asia by its third-party distributor.;
Founded in
1995
Managing director
Mr. Bal Kishan Gupta
Parent organisation
Medicamen Organics Ltd

Strength and risks

Strengths
Risks
Medicamen Organics holds ISO 9001:2015 certification for quality management systems.
As of September 30, 2023, the company's product range includes 84 products marketed globally under various brand names.
Medicamen Organics has a presence in India and overseas. It also holds approvals for product manufacturing in international markets. This includes countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, the Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan, and Kenya.
The company’s manufacturing facilities in Ranipur, Haridwar, hold WHO GMP approval.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular32 - 34₹2 Lakh
High Networth Individual32 - 34₹2 - 5 Lakh
For Medicamen IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW